Thursday , September 23 2021

Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg

Mumbai (Maharashtra) [India], Oct 19 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV.Mumbai (Maharashtra) [India], Oct 19 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV.Read More

About

Check Also

Social impact venture Charitnation helps more than 25000 families of migrant and daily wage earners during Covid-19 crisis in India

New Delhi [India], September 15 (ANI/SRV Media): India was put in lockdown to halt the …

Leave a Reply

Your email address will not be published. Required fields are marked *